U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
133261133261Low-Intermediate-Glycemic Index Caribbean Foods Versus High Glycemic Index Foods in Type 2 DiabetesCompletedNo Results AvailableType 2 Diabetes|Inflammation|Cardiovascular DiseaseDietary Supplement: Low-Intermediate-Glycemic Index diets|Dietary Supplement: High GI diethttps://ClinicalTrials.gov/show/NCT00818935
133262133262[Trial of device that is not approved or cleared by the U.S. FDA]WithheldNo Results Availablehttps://ClinicalTrials.gov/show/NCT00818922
133263133263Systane Clinical Experience StudyCompletedNo Results AvailableDry Eye SyndromeOther: Systanehttps://ClinicalTrials.gov/show/NCT00818909
133264133264Maternal Hypothyroidism in PregnancyCompletedNo Results AvailableHypothyroidismhttps://ClinicalTrials.gov/show/NCT00818896
133265133265Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone in Participants With Moderate to Severe HypertensionCompletedHas ResultsEssential HypertensionDrug: Azilsartan medoxomil and chlorthalidone|Drug: Azilsartan medoxomil and hydrochlorothiazidehttps://ClinicalTrials.gov/show/NCT00818883
133266133266Effect of Vecam 40/300 and Vecam 20/300 Compared to Omeprazole 20 mg on Gastric pHCompletedNo Results AvailableGastroesophageal RefluxDrug: Omeprazole|Drug: Vecam|Drug: Vecamhttps://ClinicalTrials.gov/show/NCT00818870
133267133267Primary Care Based Randomized Trial to Reduce Cancer Screening DisparitiesEnrolling by invitationNo Results AvailablePreventive MeasuresBehavioral: Early Intervention|Behavioral: Delayed interventionhttps://ClinicalTrials.gov/show/NCT00818857
133268133268Role of Nepafenac in Reducing Macular Volume After Epiretinal Membrane SurgeryCompletedNo Results AvailableEpiretinal MembraneDrug: Nepafenac 0.1%|Other: BSShttps://ClinicalTrials.gov/show/NCT00818844
133269133269A Study of QBI-139 in Subjects With Advanced Solid TumorsActive, not recruitingNo Results AvailableSolid TumorsDrug: QBI-139https://ClinicalTrials.gov/show/NCT00818831
133270133270Low-dose Pentavalent Antimony Treatment of Cutaneous Leishmaniasis in Old Age PatientsCompletedNo Results AvailableLocalized Cutaneous LeishmaniasisDrug: Meglumine antimoniatehttps://ClinicalTrials.gov/show/NCT00818818
133271133271Efficacy Investigation Study of Olopatadine Hydrochloride Ophthalmic Solution Using OHIO Chamber in Patients With Seasonal Allergic Rhinitis (SAR)CompletedHas ResultsAllergic ConjunctivitisDrug: Olopatadine 0.1%|Drug: Tranilast 0.5%|Drug: Placebo (Olopatadine)|Drug: Placebo (Tranilast)https://ClinicalTrials.gov/show/NCT00818805
133272133272Randomized Comparison of xiEnce and visioN Coronary Stents in the sAme muLtivessel Patient With Chronic kiDnEy diSeaseCompletedNo Results AvailableChronic Kidney Disease|Multivessel Coronary Artery DiseaseDevice: Coronary stenthttps://ClinicalTrials.gov/show/NCT00818792
133273133273Direct Renin Inhibition Effects on Atherosclerotic BiomarkersCompletedHas ResultsCoronary Artery Disease|Type 2 Diabetes MellitusDrug: Aliskiren|Drug: Amlodipinehttps://ClinicalTrials.gov/show/NCT00818779
133274133274Efficacy of Post-operative Antibiotic Prophylaxis for Thoracic Surgery Requiring Tube Thoracostomy.CompletedNo Results AvailableAntibiotic ProphylaxisDrug: cefazolin or vancomycin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00818766
133275133275Randomized, Open Label Study of Dabigatran Etexilate in Elective Percutaneous Coronary InterventionCompletedHas ResultsHeart CatheterizationDrug: dabigatran 110 mg|Drug: dabigatran 150 mg|Drug: unfractionated heparinhttps://ClinicalTrials.gov/show/NCT00818753
133276133276Pharmacokinetic Study of ORM-12741 in Healthy VolunteersCompletedNo Results AvailableHealthy VolunteersDrug: ORM-12741https://ClinicalTrials.gov/show/NCT00818740
133277133277Bone Density of Newborn Infants to Mothers Treated With Selective Serotonin Reuptake Inhibitor (SSRI)Not yet recruitingNo Results AvailableBone Densityhttps://ClinicalTrials.gov/show/NCT00818727
133278133278Stereotactic Body Radiation Therapy (SBRT) as a Boost After Definitive Concurrent Chemoradiation (ChemoRT) for Non-Small Cell Lung Cancer (NSCLC)WithdrawnNo Results AvailableNon-Small Cell Lung Cancer (NSCLC)Radiation: SBRThttps://ClinicalTrials.gov/show/NCT00818714
133279133279Study of Low Dose Nesiritide With or Without Sildenafil in Congestive Heart Failure Patients With Renal DysfunctionTerminatedNo Results AvailableCongestive Heart Failure|Renal DysfunctionDrug: low dose Nesiritide|Drug: nesiritide, Sildenafilhttps://ClinicalTrials.gov/show/NCT00818701
133280133280POST (Prospective Observational Superfial Thrombophlebitis)CompletedNo Results AvailableThrombophlebitisProcedure: compression ultrasonography at 3 monthshttps://ClinicalTrials.gov/show/NCT00818688
133281133281A Study of Ridaforolimus in Non-Small Cell Lung Cancer (NSCLC) Patients With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutations (MK-8669-021 AM1)TerminatedNo Results AvailableNon-Small Cell Lung CancerDrug: Lead-In Ridaforolimus|Drug: Comparator: Blinded Ridaforolimus|Drug: Comparator: Blinded Placebohttps://ClinicalTrials.gov/show/NCT00818675
133282133282A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s DiseaseCompletedHas ResultsAlzheimer´s DiseaseBiological: Immune Globulin Intravenous (Human), 10% (IGIV, 10%) 400 mg/kg|Biological: Immune Globulin Intravenous (Human), 10% (IGIV, 10%) 200 mg/kg|Biological: Placebo solution: Human Albumin 0.25% - 4 mL/kg|Biological: Placebo solution: Human Albumin 0.25% - 2 mL/kghttps://ClinicalTrials.gov/show/NCT00818662
133283133283Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid LeukemiaTerminatedHas ResultsLeukemia|Myelodysplastic SyndromeDrug: bortezomib|Drug: vorinostathttps://ClinicalTrials.gov/show/NCT00818649
133284133284Expressive Writing for Co-Occurring Depression and Alcohol MisuseCompletedNo Results AvailableDepression|Alcohol, DrinkingBehavioral: Expressive writing (in addition to group therapy as usual).https://ClinicalTrials.gov/show/NCT00818636
133285133285Investigation of a New Trial Drug (FE200486) in Prostate Cancer PatientsCompletedHas ResultsProstate CancerDrug: Degarelix|Drug: Degarelix|Drug: Degarelix|Drug: Degarelix|Drug: Degarelix|Drug: Degarelix|Drug: Degarelix|Drug: Degarelixhttps://ClinicalTrials.gov/show/NCT00818623
133286133286Monotherapy Versus Bitherapy in Non-severe Hospitalized Community-acquired PneumoniaCompletedNo Results AvailableCommunity-acquired PneumoniaDrug: Beta lactam (amoxicillin / clav. acid OR cefuroxime)|Drug: Beta-lactam (amoxicillin / clav. acid OR cefuroxime) AND macrolide (clarithromycin)https://ClinicalTrials.gov/show/NCT00818610
133287133287Extracorporeal Immune Support System (EISS) for the Treatment of Septic PatientsCompletedNo Results AvailableSevere Sepsis and Septic ShockDevice: EISShttps://ClinicalTrials.gov/show/NCT00818597
133288133288An Open-Label Study of the Safety and Pharmacokinetics of Repeated-Dose Micafungin in NeonatesCompletedNo Results AvailableCandidaDrug: Micafunginhttps://ClinicalTrials.gov/show/NCT00818584
133289133289Pharmacokinetics of Vildagliptin in Mild, Moderate and Severe Renal Impaired PatientsCompletedNo Results AvailableRenal Impairment|DiabetesDrug: Vildagliptin|Drug: Vildagliptin|Drug: Vildagliptin|Drug: Vildagliptinhttps://ClinicalTrials.gov/show/NCT00818571
133290133290The Method ISET (Insulation by Size of Epithelial Tumor Cells)RecruitingNo Results AvailableNon Small Cell Lung CancerBiological: ISET Methodehttps://ClinicalTrials.gov/show/NCT00818558

* Görseller ve İçerik tekif hakkına sahip olabilir